DEC 18, 2019 8:47 AM PST

Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries

WRITTEN BY: Nouran Amin

Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of research is patience. At the end, results brought some light on understating pain levels in these kinds of injuries.

"Well, it doesn't seem to be working. I don't see any real change in pain behavior in any of the groups," said Shiga, a visiting scholar at University of California San Diego School of Medicine, apologetically, as he walked into the office of his supervisor, Wendy Campana, PhD, professor in the Department of Anesthesiology and Program in Neuroscience. "Although ... some rats are actually really moving."

What is different that time is researchers added a particular ‘stroke drug’ to the stem cell recipe before injecting into the rats spinal cord. The drug consists of a modified form of tissue-type plasminogen activator (tPA) used to target blood clots in non-hemorrhagic stroke and allows the blood and adequate oxygen to run freely into the brain post-stroke. In addition, TPA is a naturally occurring enzyme known to boost neuronal cell growth and lessen inflammation.

Findings were published in Scientific Reports and describes how researchers treated neuronal precursor cells referred to as progenitors with altered tPA.

"It was striking to see at two and four months the tremendous improvements in the ability of those progenitor cells to survive in the injury cavity," added Campana. "Just keeping these cells alive has been very difficult in past studies."

Learn more about spinal cord injuries:

"The addition of tPA-treated neural precursors didn't reduce pain in this model," Campana said. "But we also didn't exacerbate it -- and to not see increased pain is important safety information for clinical translation to improve motor outcomes. We also don't want worsen the pain burden of patients living with spinal cord injuries."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
APR 17, 2020
Cannabis Sciences
APR 17, 2020
Does CBD Really Ease Arthritis Pain?
Cannabis products are increasingly used to treat chronic pain from arthritis. As its non psychoactive ingredient, cannab ...
APR 12, 2020
Drug Discovery & Development
APR 12, 2020
Can Spider-Venom Alleviate Pain?
Can spider venom offer pain relief? Apparently, yes! According to researchers at University of Queensland, compounds iso ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Teenage Cannabis Use May Prime the Brain to Enjoy Cocaine
New research has found that teenage cannabis use may make the brain more susceptible to the effects of cocaine. "It ...
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Making Recombination-Protein Drugs Cost Effective
  In a study published in Nature Communications, scientists used genome-editing techniques to eliminate up to 70 pe ...
MAY 06, 2020
Cancer
MAY 06, 2020
Olanzapine useful for cancer patients managing nausea unrelated to chemo
A study published last week in JAMA Oncology reports that a generic drug called Olanzapine could be useful for cancer pa ...
Loading Comments...